BPC-157 (Body Protective Compound-157) is a pentadecapeptide derived from a gastric protein with well-documented cytoprotective properties in preclinical models
Adherence to any GLP-1 RA formulation, measured by the proportion of days covered, was evaluated in those individuals who initiated GLP-1 RA therapy at least 180 days prior to their first FSL acquisition and had continuous prescription coverage from their FSL acquisition to their follow-up A1c measurement
It works by increasing insulin and decreasing glucagon after meals to control blood sugar and slowing down digestion (gastroparesis) to make you feel full sooner and eat less
R is short for any carbon atom
It is well documented that patients with neurofibromatosis type 1 (NF1) have a greater lifetime risk of developing MPNSTs (813%) and worse prognosis in comparison with sporadic cases, with 5-year disease-specific survival of 1638% versus 4257%, respectively [2, 5,6,7,8,9,10]
The Cellular Battery NAD (nicotinamide adenine dinucleotide) is not an antioxidant